youtube_live
Q2 2026 earnings • released • Revenue miss -0.34%
See resultschevron_right
JMKE:NYSE
Jersey Mike's Subs Inc
$22.37
arrow_upward
+7.44%(+1.55) 1D
$22.41
arrow_upward
+0.18% (+0.039)bedtimeAfter hours
Closed: Sep 9, 4:00:02 PM GMT-4 · USD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JMKE...
Open
$22.06
High
$23.79
Low
$21.51
Mkt. cap
7.11B
Avg. vol.
3.92M
Volume
0.00
P/E ratio
248.03
52-wk high
$24.99
52-wk low
$19.86
EPS
$0.09
No. of employees
899
Open
$22.06
High
$23.79
Low
$21.51
Mkt. cap
7.11B
Avg. vol.
3.92M
Volume
0.00
P/E ratio
248.03
52-wk high
$24.99
52-wk low
$19.86
EPS
$0.09
No. of employees
899
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
JMKE SWOT Analysis: Key Financial Insights Revealed in 10-Q Fili
Yahoo Finance
·
3 hours ago
Why Jersey Mike's Stock Jumped Today
News Corp
·
9 hours ago
Apple, ServiceTitan, Meta, Micron, Casey’s, Jersey Mike’s, and More Stocks That Explain Today’s Market
Morningstar
·
12 hours ago
Jersey Mike’s Earnings: Digital Marketing and Value-Oriented Offers Are Bearing Fruit
About Jersey Mike's Subs Inc
Analyst ratings
Based on 24 analysts giving stock ratings to JMKE in the past 3 months
Strong buy
Buy
20
Hold
4
Sell
0
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for JMKE in the last 3 months.
Highest
Current $22.37
$31.00 (+38.58%)
Average
$27.86 (+24.54%)
Lowest
$25.00 (+11.76%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Sharon Zackfia William Blair | Buy | Maintained | - | - | 09/09/2026 |
Andrew Charles TD Cowen | Buy | Maintained | $26.00 | +16.2% | 09/09/2026 |
Zachary Fadem Wells Fargo | Hold | Reiterated | $25.00 | +11.8% | 09/09/2026 |
Sara Senatore Bank of America Securities | Buy | Maintained | $27.00 | +20.7% | 09/08/2026 |
Ivan Feinseth Tigress Financial | Buy | Initiated | $29.00 | +29.6% | 08/26/2026 |
Leah Jordan Goldman Sachs | Hold | Initiated | $26.00 | +16.2% | 08/25/2026 |
David Palmer Evercore ISI | Buy | Initiated | $28.00 | +25.2% | 08/24/2026 |
Lauren Silberman Deutsche Bank | Buy | Initiated | $27.00 | +20.7% | 08/24/2026 |
Gregory Francfort Guggenheim | Buy | Initiated | $28.00 | +25.2% | 08/24/2026 |
Brian Vaccaro Raymond James | Buy | Initiated | $29.00 | +29.6% | 08/24/2026 |
Joseph Civello Truist Financial | Buy | Initiated | $30.00 | +34.1% | 08/24/2026 |
Danilo Gargiulo Bernstein | Hold | Initiated | $26.00 | +16.2% | 08/24/2026 |
Peter Saleh BTIG | Buy | Initiated | $28.00 | +25.2% | 08/24/2026 |
Greg Badishkanian Wolfe Research | Hold | Initiated | - | - | 08/24/2026 |
Nick Setyan Mizuho Securities | Buy | Initiated | $31.00 | +38.6% | 08/24/2026 |
Dennis Geiger UBS | Buy | Initiated | $28.00 | +25.2% | 08/24/2026 |
Andy Barish Jefferies | Buy | Initiated | $29.00 | +29.6% | 08/24/2026 |
Brian Harbour Morgan Stanley | Buy | Initiated | $29.00 | +29.6% | 08/24/2026 |
Matthew Smith, CFA Stifel Nicolaus | Buy | Initiated | $27.00 | +20.7% | 08/24/2026 |
Logan Reich RBC Capital | Buy | Initiated | $28.00 | +25.2% | 08/24/2026 |
John Ivankoe J.P. Morgan | Buy | Initiated | $26.00 | +16.2% | 08/24/2026 |
Drew North Robert W. Baird | Buy | Initiated | $27.00 | +20.7% | 08/24/2026 |
Unknown Analyst Robert W. Baird | Buy | Initiated | $27.00 | +20.7% | 08/24/2026 |
Brian Mullan Piper Sandler | Buy | Initiated | $29.00 | +29.6% | 08/24/2026 |
Jacob Aiken Phillips Melius Research | Buy | Initiated | $30.00 | +34.1% | 07/30/2026 |
Last report
Sep 9, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
- / $0.18
Revenue / Est. (USD)
208.00M / 208.72M
-0.34%miss
arrow_downward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Mar 2025 | Mar 2026 |
|---|---|---|
Revenue | 167.00M | 185.00M |
Cost of goods sold | 59.00M | 69.00M |
Cost of revenue | 59.00M | 69.00M |
Research and development expenses | - | - |
Total research and development expenses | - | - |
Selling, general, and admin expenses | 57.00M | 73.00M |
Operating expense | 78.00M | 99.00M |
Total operating expenses | 137.00M | 168.00M |
Operating income | 30.00M | 17.00M |
Other non operating income | - | - |
EBT including unusual items | 10.00M | -24.00M |
EBT excluding unusual items | 11.00M | -12.00M |
Income tax expense | - | - |
Effective tax rate | - | - |
Other operating expenses | - | - |
Net income | 10.00M | -24.00M |
Net profit margin | 5.99% | -12.97% |
Earnings per share | - | - |
Interest and investment income | 4.00M | 1.00M |
Interest expense | -23.00M | -30.00M |
Net interest expenses | -19.00M | -29.00M |
Depreciation and amortization charges | 21.00M | 26.00M |
EBITDA | 51.00M | 43.00M |
Gain or loss from assets sale | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1